Flurry Of Cancer Pacts
Monday, January 2, 2012 - 01:20
in Health & Medicine
Takeda, Merck & Co., Eli Lilly & Co., AstraZeneca move to gain access to oncology drug candidates.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via